Tumor Necrosis Factor Alpha Gene Polymorphisms Increase Susceptibility to Adenovirus Infection in Children and Are Correlated with Severity of Adenovirus-Associated Pneumonia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Zhang S;Zhang S; Zhan L; Zhan L; Zhu Y; Zhu Y; Sun H; Sun H; Xu X; Xu X
  • Source:
    Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2020 Dec; Vol. 24 (12), pp. 761-770. Date of Electronic Publication: 2020 Dec 02.
  • Publication Type:
    Comparative Study; Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-0257 (Electronic) Linking ISSN: 19450257 NLM ISO Abbreviation: Genet Test Mol Biomarkers Subsets: MEDLINE
    • Publication Information:
      Original Publication: New Rochelle, NY : Mary Ann Liebert, Inc.
    • Subject Terms:
    • Abstract:
      Objective: To study the relationships between single nucleotide polymorphisms (SNPs) in the intron of the tumor necrosis factor α ( TNFα ) gene and the susceptibility and severity of disease associated with adenovirus infection in children. Methods: Four polymorphic loci of the TNFα gene (rs3093661, rs1800610, rs3093662, and rs3093664) were characterized allelically and genotypically in 320 children with adenovirus-associated pneumonia (AP) and compared with 320 healthy controls. Enzyme-linked immunosorbent assays (ELISAs) were used to detect the plasma TNFα protein levels in all subjects. Results: The TNFα gene rs3093661 locus A allele, the rs1800610 locus A allele, the rs3093662 locus G allele, and the rs3093664 locus G allele were identified as susceptibility alleles for development of AP, and they were also positively correlated with the severity of AP. In children who had the GGAA haplotype, AP susceptibility was significantly reduced (0.28-fold) (95% confidence interval, CI: 0.20-0.40, p  < 0.001). Conversely, among the subjects with the AGGG haplotype, their AP susceptibility risk was significantly increased (2.76-fold) (95% CI: 1.77-4.29, p  < 0.001); and in the subjects with the AP GGGG haplotype their AP susceptibility risk was significantly increased (2.49-fold) (95% CI: 1.67-3.72, p  < 0.001). The TNFα rs3093661, rs1800610, rs3093662, and rs3093664 SNPs were significantly correlated with plasma TNFα levels ( p  < 0.05). Conclusion: The TNFα gene rs3093661, rs1800610, rs3093662, and rs3093664 loci are associated with AP susceptibility and severity. This relationship might be due to the effect on TNFα levels found in the plasma. Clinical Trial Registration number: LL20190723.
    • References:
      Clin Infect Dis. 2001 May 15;32(10):1423-9. (PMID: 11317242)
      Int J Mol Sci. 2020 Jan 24;21(3):. (PMID: 31991572)
      Mol Carcinog. 2013 Nov;52 Suppl 1:E70-9. (PMID: 23423739)
      Pediatr Res. 2006 May;59(5):641-5. (PMID: 16627874)
      Curr Pharm Biotechnol. 2016;17(6):486-94. (PMID: 26927216)
      Cold Spring Harb Perspect Biol. 2018 Oct 1;10(10):. (PMID: 28847899)
      Future Virol. 2011 Mar;6(3):357-374. (PMID: 21738557)
      Sci Signal. 2018 Jan 02;11(511):. (PMID: 29295955)
      Crit Care Med. 2005 Apr;33(4):772-9. (PMID: 15818104)
      Int J Pediatr Otorhinolaryngol. 2015 Apr;79(4):481-6. (PMID: 25639552)
      Medicine (Baltimore). 2016 May;95(18):e3577. (PMID: 27149483)
      J Clin Virol. 2010 Oct;49(2):115-20. (PMID: 20692203)
      Vet Microbiol. 2019 Jul;234:25-33. (PMID: 31213269)
      Mol Cell Biochem. 2016 Jan;411(1-2):191-9. (PMID: 26446017)
      Respir Med. 2013 Nov;107(11):1810-3. (PMID: 24070567)
      Am J Respir Crit Care Med. 2007 Dec 1;176(11):1072-8. (PMID: 17901411)
      J Clin Med. 2019 Dec 20;9(1):. (PMID: 31877657)
      Ann N Y Acad Sci. 2000;923:68-77. (PMID: 11193780)
      Arch Otolaryngol Head Neck Surg. 2011 Apr;137(4):401-3. (PMID: 21502481)
    • Contributed Indexing:
      Keywords: adenovirus pneumonia; enzyme-linked immunosorbent assay; single nucleotide polymorphisms; tumor necrosis factor α
    • Accession Number:
      0 (TNF protein, human)
      0 (Tumor Necrosis Factor-alpha)
    • Publication Date:
      Date Created: 20201203 Date Completed: 20210712 Latest Revision: 20211203
    • Publication Date:
      20240104
    • Accession Number:
      PMC7755857
    • Accession Number:
      10.1089/gtmb.2020.0122
    • Accession Number:
      33270503